Boxer Capital, LLC
- SEC CIK
- 0001465837
- 最新申報
- 2025/2/14
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/14 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 70
- 較 2021 年第 3 季 −17
- 總值
- $25.1 億
- 較 2021 年第 3 季 −$3.50 億 (−12.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $2.93 億 | 11.7% | 00.0% | 不變 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 2,200,000 | $2.46 億 | 9.8% | +2,200,000 | 新進 | – |
| ITOSiTeos Therapeutics, Inc. | COM | 4,345,016 | $2.02 億 | 8.0% | 00.0% | 不變 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $1.35 億 | 5.4% | −264,188−34.6% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,075,905 | $1.29 億 | 5.1% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $9,572 萬 | 3.8% | 00.0% | 不變 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $9,073 萬 | 3.6% | +125,000+2.0% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 3,484,264 | $8,770 萬 | 3.5% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,669,132 | $8,197 萬 | 3.3% | +1,375,000+106.2% | 加碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 6,871,642 | $7,518 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,838,236 | $6,556 萬 | 2.6% | +570,000+25.1% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 1,900,000 | $6,042 萬 | 2.4% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 1,432,200 | $5,796 萬 | 2.3% | −652,683−31.3% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 507,374 | $5,435 萬 | 2.2% | +82,374+19.4% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $5,207 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $4,654 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $4,518 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 4,341,009 | $3,690 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $3,546 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 1,847,559 | $3,274 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $3,200 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| FATEFate Therapeutics Inc | COM | 500,000 | $2,926 萬 | 1.2% | +500,000 | 新進 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 2,462,358 | $2,785 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $2,685 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $2,665 萬 | 1.1% | 00.0% | 不變 | – |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $2,576 萬 | 1.0% | +225,000+7.6% | 加碼 | – |
| GHRSGH Research PLC | ORDINARY SHARES | 1,013,399 | $2,364 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $2,304 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,100,000 | $2,100 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $2,005 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $1,874 萬 | 0.7% | −257,000−30.0% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 1,526,048 | $1,811 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $1,759 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 200,000 | $1,682 萬 | 0.7% | +200,000 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $1,657 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 1,175,000 | $1,513 萬 | 0.6% | 00.0% | 不變 | – |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $1,482 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,238,861 | $1,467 萬 | 0.6% | −333,333−13.0% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | $1,409 萬 | 0.6% | −83,090−6.2% | 減碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $1,400 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| BCABBioAtla, Inc. | COM | 686,347 | $1,347 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| THRXTheseus Pharmaceuticals, Inc. | COM | 892,057 | $1,131 萬 | 0.5% | +892,057 | 新進 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $1,074 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $1,071 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 724,500 | $1,029 萬 | 0.4% | +37,500+5.5% | 加碼 | 歷史 |
| CDAKCodiak BioSciences, Inc. | COM | 850,065 | $947.0 萬 | 0.4% | −180,000−17.5% | 減碼 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $885.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 1,188,405 | $885.4 萬 | 0.4% | −900,000−43.1% | 減碼 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $777.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| EQRXEQRx, Inc. | COM | 1,000,000 | $682.0 萬 | 0.3% | +1,000,000 | 新進 | 歷史 |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $667.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 4,207,086 | $568.0 萬 | 0.2% | −1,400,000−25.0% | 減碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 3,177,702 | $556.1 萬 | 0.2% | −556,872−14.9% | 減碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 872,780 | $525.4 萬 | 0.2% | −468,750−34.9% | 減碼 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $490.0 萬 | 0.2% | 00.0% | 不變 | – |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $488.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $488.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $485.0 萬 | 0.2% | 00.0% | 不變 | – |
| ACADAcadia Pharmaceuticals Inc | COM | 185,000 | $431.8 萬 | 0.2% | +185,000 | 新進 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $403.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $395.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 1,300,000 | $378.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 2,134,598 | $341.5 萬 | 0.1% | −5,400,000−71.7% | 減碼 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 200,000 | $294.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 540,000 | $204.7 萬 | 0.1% | −1,063,361−66.3% | 減碼 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 200,000 | $195.4 萬 | 0.1% | 00.0% | 不變 | – |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $141.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 1,134,453 | $131.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SRZNSurrozen, Inc. | COM | 200,000 | $128.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $50.4 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPDR Ser Tr78464A900 | CALL | – | $6,158 萬 |
2021 年第 3 季之後清倉（23 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 3 季股數 | 2021 年第 3 季市值 | 2021 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 170,926 | $5,162 萬 | 1.8% | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | ADS | 2,081,323 | $5,043 萬 | 1.8% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,287,782 | $4,372 萬 | 1.5% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 1,250,000 | $3,526 萬 | 1.2% | 歷史 |
| TPTXTurning Point Therapeutics, Inc. | COM | 525,000 | $3,488 萬 | 1.2% | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 2,400,000 | $2,731 萬 | 1.0% | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,050,289 | $1,967 萬 | 0.7% | 歷史 |
| PASGPassage BIO, Inc. | COM | 1,928,315 | $1,921 萬 | 0.7% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 1,675,377 | $1,672 萬 | 0.6% | 歷史 |
| FSTXF-star Therapeutics, Inc. | COM | 1,751,428 | $1,282 萬 | 0.4% | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,536,016 | $1,197 萬 | 0.4% | – |
| NGNENeurogene Inc. | COM | 1,501,058 | $1,085 萬 | 0.4% | 歷史 |
| TLISTalis Biomedical Corp | COM | 1,550,998 | $969.4 萬 | 0.3% | 歷史 |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 2,500,000 | $967.5 萬 | 0.3% | 歷史 |
| ERASErasca, Inc. | COM | 450,000 | $954.9 萬 | 0.3% | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 450,000 | $727.7 萬 | 0.3% | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 1,500,000 | $522.0 萬 | 0.2% | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 750,000 | $460.5 萬 | 0.2% | 歷史 |
| LJPCLa Jolla Pharmaceutical Co | COM PAR $.0001 2 | 890,700 | $355.4 萬 | 0.1% | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 290,577 | $331.0 萬 | 0.1% | 歷史 |
| Direxion Shs ETF Tr25460G716 | DAILY S&P BIOTEC | 150,000 | $319.5 萬 | 0.1% | – |
| SNCEScience 37 Holdings, Inc. | COM | 200,000 | $196.0 萬 | 0.1% | 歷史 |
| CLRBCellectar Biosciences, Inc. | COM PAR | 920,000 | $85.1 萬 | <0.1% | 歷史 |